Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY: ZBH )

108.40 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 Next >
What 21 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Via Benzinga
(ZBH) - Analyzing Zimmer Biomet Holdings's Short Interest
Via Benzinga
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts
Zimmer Biomet's sales are up 4% to $1.82 billion. Knee and hip products grew, while 2024 EPS guidance was slightly lowered. 
Via Benzinga
McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Analyst Expectations For Zimmer Biomet Holdings's Future
Via Benzinga
Looking Into Zimmer Biomet Holdings's Recent Short Interest
Via Benzinga
Navigating 14 Analyst Ratings For Zimmer Biomet Holdings
Via Benzinga
Assessing Zimmer Biomet Holdings: Insights From 8 Financial Analysts
Via Benzinga
Where Zimmer Biomet Holdings Stands With Analysts
Via Benzinga
Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
The FDA has issued a warning about the increased risk of thigh bone fractures associated with Zimmer Biomet's CPT Hip System. 
Via Benzinga
Exposures Product Safety
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Zimmer Biomet Hammered, Sales Expected To Take A Surprise 1% Hit
The company is well known for its hip and knee replacements. Full-year sales will take an unexpected hit. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ZBH Stock Earnings: Zimmer Biomet Holdings Beats EPS, Beats Revenue for Q2 2024
ZBH stock results show that Zimmer Biomet Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Peering Into Zimmer Biomet Holdings's Recent Short Interest
Via Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Zimmer Biomet Holdings
Via Benzinga
Analyst Expectations For Zimmer Biomet Holdings's Future
Via Benzinga
3 Healthcare Stocks to Buy at a 52-Week Low in July
At their 52-week lows, these undervalued healthcare stocks present a favorable return supported by healthcare spending tailwinds. 
Via InvestorPlace
ZimVie Stock Launches 15% Into Breakout Territory On Rumored Takeover
The company spun out from Zimmer Biomet in 2022. Now, it's a possible takeover candidate. 
Via Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper highlights five stocks that caught an increased amount of attention from readers and investors during the week. 
Via Benzinga
Orthopedic Implants Maker Zimmer Biomet Gains Analyst Upgrade Amid Promising Growth From New Products, Demographic Trends
Zimmer Biomet receives an upgrade from Argus Research due to new product launches and strategic acquisitions. 
Via Benzinga
Top Stock Reports For Amazon.com, Visa & Pfizer
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Visa Inc.. and Pfizer Inc. 
Via Talk Markets
Unveiling 7 Analyst Insights On Zimmer Biomet Holdings
Via Benzinga
What 7 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Via Benzinga
Why Is Zimmer Biomet Stock Trading Lower Today?
Zimmer Biomet's Q4 2023 results, featuring 6.3% Y/Y net sales growth, $2.20 adjusted EPS, and a global restructuring plan for $200M cost savings. 
Via Benzinga
(ZBH) - Analyzing Zimmer Biomet Holdings's Short Interest
Via Benzinga
What's Going On With Zimmer Biomet Shares After Q1 Earnings?
Zimmer Biomet beats Q1 earnings and sales estimates, with adjusted EPS at $1.94 and quarterly sales hitting $1.889 billion, prompting a slight dip in shares. 
Via Benzinga
Worried About Inflation? 3 Stocks Built to Thrive in a High-Price Environment
With prices remaining elevated above historical norms, investors still are interested in buying inflation-resistant stocks. 
Via InvestorPlace
ZBH Stock Earnings: Zimmer Biomet Holdings Beats EPS, Beats Revenue for Q1 2024
ZBH stock results show that Zimmer Biomet Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.